T-CELL LEUKEMIA
Clinical trials for T-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Turning Patients' own cells against a rare and aggressive cancer
Disease control Recruiting nowThis early-stage trial is testing a new type of personalized cell therapy called CD4CAR for adults and teens with T-cell leukemia or lymphoma that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, genetically engineer them in a…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Drug trial aims to stop cancer before it starts in High-Risk patients
Prevention Recruiting nowThis study is testing whether the drug mogamulizumab can prevent a serious type of blood cancer called adult T-cell leukemia/lymphoma (ATL) from developing. It is for people who carry the HTLV-1 virus and have specific changes in their immune cells that put them at high risk for …
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Mar 27, 2026 12:38 UTC
-
Researchers gather clues to fight aggressive blood cancer
Knowledge-focused Recruiting nowThis study aims to collect detailed medical information from people with a rare and aggressive type of blood cancer called T-cell prolymphocytic leukemia. Researchers will gather data on patient characteristics, treatments, and outcomes to better understand the disease. The goal …
Matched conditions: T-CELL LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC